Old Web
English
Sign In
Acemap
>
authorDetail
>
Kenneth N Sall
Kenneth N Sall
Research Medical Center
Medicine
Ophthalmology
Physical therapy
Phase (matter)
Perfluorohexyloctane
3
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety and Efficacy of KPI-121 Ophthalmic Suspension 0.25% for Dry Eye Disease in Three Phase Three Randomized Controlled Trials
2021
Edward J. Holland
Terry Kim
Kelly K. Nichols
Gary N. Foulks
Preeya K. Gupta
Kenneth N Sall
Susan Coultas
Kim Brazzell
Show All
Source
Cite
Save
Citations (0)
Effects of Perfluorohexyloctane on Signs and Symptoms of Dry Eye Disease: SEECASE-1: Subgroup Analysis based on Baseline Characteristics
2020
Investigative Ophthalmology & Visual Science
Kenneth N Sall
Daniela Willen
Sonja Krösser
Joseph Tauber
Show All
Source
Cite
Save
Citations (0)
A Phase 2 Multicenter, Randomized, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of CBT-001 for Pterygia
2019
Investigative Ophthalmology & Visual Science
Scott M. Whitcup
Kenneth N Sall
John A. Hovanesian
Damien F. Goldberg
Paula Bernstein
Olivia L Lee
Show All
Source
Cite
Save
Citations (0)
1